{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T12:36:14Z","timestamp":1785242174254,"version":"3.55.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jsat.2019.11.002","type":"journal-article","created":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T23:18:15Z","timestamp":1572995895000},"page":"14-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Predictors of initiation of and retention on medications for alcohol use disorder among people living with and without HIV"],"prefix":"10.1016","volume":"109","author":[{"given":"Benjamin J.","family":"Oldfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen A.","family":"McGinnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Jennifer","family":"Edelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily C.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Akg\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Crystal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn E.","family":"Fiellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie R.","family":"Gaither","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph L.","family":"Goulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Todd","family":"Korthuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon D.L.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy C.","family":"Justice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendall","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Fiellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin L.","family":"Kraemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jsat.2019.11.002_bb0005","doi-asserted-by":"crossref","first-page":"669","DOI":"10.15288\/jsad.2011.72.669","article-title":"A longitudinal examination of alcohol pharmacotherapy adoption in substance use disorder treatment programs: Patterns of sustainability and discontinuation","volume":"72","author":"Abraham","year":"2011","journal-title":"Journal of Studies on Alcohol and Drugs"},{"issue":"6","key":"10.1016\/j.jsat.2019.11.002_bb0010","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.addbeh.2011.01.030","article-title":"Counselor attitudes toward the use of naltrexone in substance abuse treatment: A multi-level modeling approach","volume":"36","author":"Abraham","year":"2011","journal-title":"Addictive Behaviors"},{"issue":"S1","key":"10.1016\/j.jsat.2019.11.002_bb0015","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.2105\/AJPH.2018.304883","article-title":"The National Institute on Minority Health and Health Disparities Research Framework","volume":"109","author":"Alvidrez","year":"2019","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.jsat.2019.11.002_bb0020","series-title":"Practice guideline for the pharmacological treatment of patients with alcohol use disorder","author":"American Psychiatric Association","year":"2018"},{"issue":"4","key":"10.1016\/j.jsat.2019.11.002_bb0025","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1530-0277.2007.00343.x","article-title":"What role does measuring medication compliance play in evaluating the efficacy of naltrexone?","volume":"31","author":"Baros","year":"2007","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"3","key":"10.1016\/j.jsat.2019.11.002_bb0030","first-page":"280","article-title":"Influence of alcohol consumption on adherence to and toxicity of antiretroviral therapy and survival","volume":"33","author":"Braithwaite","year":"2010","journal-title":"Alcohol Research & Health"},{"key":"10.1016\/j.jsat.2019.11.002_bb0035","series-title":"Incorporating alcohol pharmacotherapies into medical practice: Treatment improvement protocol series, no. 49","author":"Center for Substance Abuse Treatment","year":"2009"},{"key":"10.1016\/j.jsat.2019.11.002_bb0040","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.drugalcdep.2016.01.015","article-title":"HIV primary care providers\u2014Screening, knowledge, attitudes and behaviors related to alcohol interventions","volume":"161","author":"Chander","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"issue":"12","key":"10.1016\/j.jsat.2019.11.002_bb0045","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/MLR.0000000000000818","article-title":"State variation in quality outcomes and disparities in outcomes in community health centers","volume":"55","author":"Cole","year":"2017","journal-title":"Medical Care"},{"issue":"4","key":"10.1016\/j.jsat.2019.11.002_bb0050","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00126334-200308010-00014","article-title":"How harmful is hazardous alcohol use and abuse in HIV infection: Do health care providers know who is at risk?","volume":"33","author":"Conigliaro","year":"2003","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.jsat.2019.11.002_bb0055","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1940-0640-8-12","article-title":"Prescription of topiramate to treat alcohol use disorders in the Veterans Health Administration","volume":"8","author":"Del Re","year":"2013","journal-title":"Addiction Science & Clinical Practice"},{"issue":"1","key":"10.1016\/j.jsat.2019.11.002_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13722-015-0048-z","article-title":"Implementation of integrated stepped care for unhealthy alcohol use in HIV clinics","volume":"11","author":"Edelman","year":"2016","journal-title":"Addiction Science & Clinical Practice"},{"key":"10.1016\/j.jsat.2019.11.002_bb0065","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cct.2016.11.008","article-title":"The Starting Treatment for Ethanol in Primary care Trials (STEP Trials): Protocol for three parallel multi-site stepped care effectiveness studies for unhealthy alcohol use in HIV-positive patients","volume":"52","author":"Edelman","year":"2017","journal-title":"Contemporary Clinical Trials"},{"key":"10.1016\/j.jsat.2019.11.002_bb0070","article-title":"Efficacy of extended-release naltrexone on HIV-related and drinking outcomes among HIV-positive patients: A randomized-controlled trial","author":"Edelman","year":"2018","journal-title":"AIDS and Behavior"},{"issue":"1","key":"10.1016\/j.jsat.2019.11.002_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/QCO.0000000000000422","article-title":"Addressing unhealthy alcohol use among people living with HIV: Recent advances and research directions","volume":"31","author":"Edelman","year":"2018","journal-title":"Current Opinion in Infectious Diseases"},{"issue":"10","key":"10.1016\/j.jsat.2019.11.002_bb0080","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1080\/09540121.2015.1050983","article-title":"Patient and provider priorities for self-reported domains of HIV clinical care","volume":"27","author":"Fredericksen","year":"2015","journal-title":"AIDS Care"},{"issue":"3","key":"10.1016\/j.jsat.2019.11.002_bb0085","first-page":"237","article-title":"Focus on the heart: Alcohol consumption, HIV infection, and cardiovascular disease","volume":"33","author":"Freiberg","year":"2010","journal-title":"Alcohol Research & Health"},{"issue":"2","key":"10.1016\/j.jsat.2019.11.002_bb0090","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/QAI.0b013e3181c6c4b7","article-title":"The association between alcohol consumption and prevalent cardiovascular diseases among HIV-infected and HIV-uninfected men","volume":"53","author":"Freiberg","year":"2010","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"10152","key":"10.1016\/j.jsat.2019.11.002_bb0095","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0140-6736(18)31310-2","article-title":"Alcohol use and burden for 195 countries and territories, 1990\u20132016: A systematic analysis for the Global Burden of Disease Study 2016","volume":"392","year":"2018","journal-title":"Lancet"},{"issue":"10053","key":"10.1016\/j.jsat.2019.11.002_bb0100","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S0140-6736(16)31679-8","article-title":"Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990\u20132015: A systematic analysis for the Global Burden of Disease Study 2015","volume":"388","year":"2016","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jsat.2019.11.002_bb0105","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/jama.2015.6447","article-title":"Quality indicators for physical and behavioral health care integration","volume":"314","author":"Goldman","year":"2015","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.jsat.2019.11.002_bb0110","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1001\/jamapsychiatry.2017.2161","article-title":"Prevalence of 12-month alcohol use, high-risk drinking, and DSM-IV alcohol use disorder in the United States, 2001\u20132002 to 2012\u20132013: Results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"74","author":"Grant","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.jsat.2019.11.002_bb0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13722-016-0063-8","article-title":"Multifaceted academic detailing program to increase pharmacotherapy for alcohol use disorder: Interrupted time series evaluation of effectiveness","volume":"11","author":"Harris","year":"2016","journal-title":"Addiction Science & Clinical Practice"},{"issue":"4","key":"10.1016\/j.jsat.2019.11.002_bb0120","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1176\/ps.2010.61.4.392","article-title":"Pharmacotherapy of alcohol use disorders in the Veterans Health Administration","volume":"61","author":"Harris","year":"2010","journal-title":"Psychiatric Services"},{"issue":"7","key":"10.1016\/j.jsat.2019.11.002_bb0125","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1176\/appi.ps.201000553","article-title":"Pharmacotherapy of alcohol use disorders by the Veterans Health Administration: Patterns of receipt and persistence","volume":"63","author":"Harris","year":"2012","journal-title":"Psychiatric Services"},{"issue":"7","key":"10.1016\/j.jsat.2019.11.002_bb0130","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.2105\/AJPH.2004.042432","article-title":"Rural definitions for health policy and research","volume":"95","author":"Hart","year":"2005","journal-title":"American Journal of Public Health"},{"issue":"2","key":"10.1016\/j.jsat.2019.11.002_bb0140","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1001\/jamainternmed.2017.7856","article-title":"Gabapentinoid use in the United States 2002 through 2015","volume":"178","author":"Johansen","year":"2018","journal-title":"JAMA Internal Medicine"},{"issue":"14","key":"10.1016\/j.jsat.2019.11.002_bb0145","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.298.14.1641","article-title":"Topiramate for treating alcohol dependence: A randomized controlled trial","volume":"298","author":"Johnson","year":"2007","journal-title":"JAMA"},{"issue":"18","key":"10.1016\/j.jsat.2019.11.002_bb0150","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2014.3628","article-title":"Pharmacotherapy for adults with alcohol use disorders in outpatient settings: A systematic review and meta-analysis","volume":"311","author":"Jonas","year":"2014","journal-title":"JAMA"},{"issue":"8 Suppl 2","key":"10.1016\/j.jsat.2019.11.002_bb0155","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/01.mlr.0000223741.02074.66","article-title":"Veterans Aging Cohort Study (VACS): Overview and description","volume":"44","author":"Justice","year":"2006","journal-title":"Medical Care"},{"key":"10.1016\/j.jsat.2019.11.002_bb0160","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2016.01.017","article-title":"Risk of mortality and physiologic injury evident with lower alcohol exposure among HIV infected compared with uninfected men","volume":"161","author":"Justice","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"issue":"12","key":"10.1016\/j.jsat.2019.11.002_bb0165","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.2105\/AJPH.2005.077628","article-title":"Advancing health disparities research within the health care system: A conceptual framework","volume":"96","author":"Kilbourne","year":"2006","journal-title":"American Journal of Public Health"},{"issue":"2","key":"10.1016\/j.jsat.2019.11.002_bb0170","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/QAI.0b013e31826741aa","article-title":"Unhealthy alcohol and illicit drug use are associated with decreased quality of HIV care","volume":"61","author":"Korthuis","year":"2012","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"6","key":"10.1016\/j.jsat.2019.11.002_bb0175","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/add.13753","article-title":"Feasibility and safety of extended-release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: A pilot\/feasibility randomized trial","volume":"112","author":"Korthuis","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2019.11.002_bb0180","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jsat.2019.05.007","article-title":"Low levels of initiation, engagement, and retention in substance use disorder treatment including pharmacotherapy among HIV-infected and uninfected veterans","volume":"103","author":"Kraemer","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"10","key":"10.1016\/j.jsat.2019.11.002_bb0185","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.ebiom.2015.08.040","article-title":"Risk of all-cause mortality in alcohol-dependent individuals: A systematic literature review and meta-analysis","volume":"2","author":"Laramee","year":"2015","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.jsat.2019.11.002_bb0190","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11096-013-9865-x","article-title":"Assessing medication adherence: Options to consider","volume":"36","author":"Lehmann","year":"2014","journal-title":"International Journal of Clinical Pharmacy"},{"issue":"24","key":"10.1016\/j.jsat.2019.11.002_bb0195","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1056\/NEJMra1805981","article-title":"Substance-use disorders in later life","volume":"379","author":"Lehmann","year":"2018","journal-title":"The New England Journal of Medicine"},{"issue":"10","key":"10.1016\/j.jsat.2019.11.002_bb0200","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/cid\/ciu097","article-title":"Relationship between alcohol use categories and noninvasive markers of advanced hepatic fibrosis in HIV-infected, chronic hepatitis C virus-infected, and uninfected patients","volume":"58","author":"Lim","year":"2014","journal-title":"Clinical Infectious Diseases"},{"issue":"1\u20133","key":"10.1016\/j.jsat.2019.11.002_bb0205","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.drugalcdep.2008.07.018","article-title":"Alcohol and opioid dependence medications: Prescription trends, overall and by physician specialty","volume":"99","author":"Mark","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.jsat.2019.11.002_bb0210","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/jamainternmed.2013.11950","article-title":"Gabapentin treatment for alcohol dependence: A randomized clinical trial","volume":"174","author":"Mason","year":"2014","journal-title":"JAMA Internal Medicine"},{"issue":"9","key":"10.1016\/j.jsat.2019.11.002_bb0215","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-022982","article-title":"Strategies to improve adherence to antiretroviral therapy and retention in care for people living with HIV in high-income countries: A protocol for an overview of systematic reviews","volume":"8","author":"Mbuagbaw","year":"2018","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.jsat.2019.11.002_bb0220","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s10461-015-1053-7","article-title":"Number of drinks to \u201cfeel a buzz\u201d by HIV status and viral load in men","volume":"20","author":"McGinnis","year":"2016","journal-title":"AIDS and Behavior"},{"issue":"1\u20132","key":"10.1016\/j.jsat.2019.11.002_bb0225","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugalcdep.2007.12.006","article-title":"HIV-positive patients' discussion of alcohol use with their HIV primary care providers","volume":"95","author":"Metsch","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"issue":"9859","key":"10.1016\/j.jsat.2019.11.002_bb0230","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990\u20132010: A systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Murray","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jsat.2019.11.002_bb0235","author":"National Institute on Alcohol Abuse and Alcoholism"},{"issue":"6","key":"10.1016\/j.jsat.2019.11.002_bb0240","doi-asserted-by":"crossref","first-page":"852","DOI":"10.15288\/jsad.2007.68.852","article-title":"Organizational-level predictors of adoption across time: Naltrexone in private substance-use disorders treatment centers","volume":"68","author":"Oser","year":"2007","journal-title":"Journal of Studies on Alcohol and Drugs"},{"issue":"4","key":"10.1016\/j.jsat.2019.11.002_bb0245","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jsat.2007.08.003","article-title":"A categorical typology of naltrexone-adopting private substance abuse treatment centers","volume":"34","author":"Oser","year":"2008","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.jsat.2019.11.002_bb0250","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1300\/J069v19n01_06","article-title":"Improving naltrexone response: An intervention for medical practitioners to enhance medication compliance in alcohol dependent patients","volume":"19","author":"Pettinati","year":"2000","journal-title":"Journal of Addictive Diseases"},{"issue":"6","key":"10.1016\/j.jsat.2019.11.002_bb0255","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1377\/hlthaff.2016.0027","article-title":"Quality measures for mental health and substance use: Gaps, opportunities, and challenges","volume":"35","author":"Pincus","year":"2016","journal-title":"Health Aff (Millwood)"},{"issue":"2","key":"10.1016\/j.jsat.2019.11.002_bb0260","first-page":"135","article-title":"The risks associated with alcohol use and alcoholism","volume":"34","author":"Rehm","year":"2011","journal-title":"Alcohol Research & Health"},{"issue":"9682","key":"10.1016\/j.jsat.2019.11.002_bb0265","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0140-6736(09)60746-7","article-title":"Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders","volume":"373","author":"Rehm","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jsat.2019.11.002_bb0270","article-title":"Medical intensive care unit admission among patients with and without HIV, hepatitis C virus, and alcohol-related diagnoses in the United States: A national, retrospective cohort study, 1997\u20132014","author":"Rentsch","year":"2018","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"1","key":"10.1016\/j.jsat.2019.11.002_bb0275","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1176\/appi.ajp.2017.1750101","article-title":"The American Psychiatric Association practice guideline for the pharmacological treatment of patients with alcohol use disorder","volume":"175","author":"Reus","year":"2018","journal-title":"The American Journal of Psychiatry"},{"issue":"9","key":"10.1016\/j.jsat.2019.11.002_bb0280","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1111\/add.12231","article-title":"Alcohol use disorders and mortality: A systematic review and meta-analysis","volume":"108","author":"Roerecke","year":"2013","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.jsat.2019.11.002_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087366","article-title":"Disulfiram efficacy in the treatment of alcohol dependence: A meta-analysis","volume":"9","author":"Skinner","year":"2014","journal-title":"PLoS One"},{"issue":"3 Suppl","key":"10.1016\/j.jsat.2019.11.002_bb0290","doi-asserted-by":"crossref","first-page":"92S","DOI":"10.1177\/1077558703256726","article-title":"Pharmacy data in the VA health care system","volume":"60","author":"Smith","year":"2003","journal-title":"Medical Care Research and Review"},{"issue":"4","key":"10.1016\/j.jsat.2019.11.002_bb0295","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1001\/jama.1990.03440040088034","article-title":"Principles of educational outreach (\u2018academic detailing\u2019) to improve clinical decision making","volume":"263","author":"Soumerai","year":"1990","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jsat.2019.11.002_bb0300","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/QAI.0000000000001634","article-title":"Extended-release naltrexone improves viral suppression among incarcerated persons living with HIV with opioid use disorders transitioning to the community: Results of a double-blind, placebo-controlled randomized trial","volume":"78","author":"Springer","year":"2018","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.jsat.2019.11.002_bb0305","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.drugalcdep.2017.01.026","article-title":"Extended-release naltrexone reduces alcohol consumption among released prisoners with HIV disease as they transition to the community","volume":"174","author":"Springer","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.jsat.2019.11.002_bb0310","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/QAI.0000000000001759","article-title":"Extended-release naltrexone improves viral suppression among incarcerated persons living with HIV and alcohol use disorders transitioning to the community: Results from a double-blind, placebo-controlled trial","volume":"79","author":"Springer","year":"2018","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.jsat.2019.11.002_bb0315","author":"Substance Abuse and Mental Health Services Administration"},{"issue":"2","key":"10.1016\/j.jsat.2019.11.002_bb0320","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1530-0277.2011.01601.x","article-title":"Hepatic safety and antiretroviral effectiveness in HIV-infected patients receiving naltrexone","volume":"36","author":"Tetrault","year":"2012","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"1","key":"10.1016\/j.jsat.2019.11.002_bb0325","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jsat.2010.08.005","article-title":"Advancing performance measures for use of medications in substance abuse treatment","volume":"40","author":"Thomas","year":"2011","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2S","key":"10.1016\/j.jsat.2019.11.002_bb0330","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.36076\/ppj.2017.s151","article-title":"Educational outreach to opioid prescribers: The case for academic detailing","volume":"20","author":"Davis","year":"2017","journal-title":"Pain Physician"},{"key":"10.1016\/j.jsat.2019.11.002_bb0335","author":"U.S. Department of Veterans Affairs"},{"key":"10.1016\/j.jsat.2019.11.002_bb0340","author":"Veterans Health Administration"},{"issue":"8","key":"10.1016\/j.jsat.2019.11.002_bb0345","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/jama.2017.21897","article-title":"Gabapentin approvals, off-label use, and lessons for postmarketing evaluation efforts","volume":"319","author":"Wallach","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jsat.2019.11.002_bb0350","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jsat.2015.07.007","article-title":"Engagement and substance dependence in a primary care-based addiction treatment program for people infected with HIV and people at high-risk for HIV infection","volume":"59","author":"Walley","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2019.11.002_bb0365","series-title":"Alcoholic thinking: Language, culture, and belief in alcoholics anonymous","author":"Wilcox","year":"1998"},{"key":"10.1016\/j.jsat.2019.11.002_bb0370","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jsat.2018.06.001","article-title":"Developing an opioid use disorder treatment cascade: A review of quality measures","volume":"91","author":"Williams","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2019.11.002_bb0375","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.drugalcdep.2017.06.011","article-title":"Variation in receipt of pharmacotherapy for alcohol use disorders across racial\/ethnic groups: A national study in the U.S. Veterans Health Administration","volume":"178","author":"Williams","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.jsat.2019.11.002_bb0380","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1037\/a0022102","article-title":"Strategies to implement alcohol screening and brief intervention in primary care settings: A structured literature review","volume":"25","author":"Williams","year":"2011","journal-title":"Psychology of Addictive Behaviors"},{"key":"10.1016\/j.jsat.2019.11.002_bb0385","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.drugalcdep.2017.01.018","article-title":"Among patients with unhealthy alcohol use, those with HIV are less likely than those without to receive evidence-based alcohol-related care: A national VA study","volume":"174","author":"Williams","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2019.11.002_bb0390","article-title":"Level of alcohol use associated with HIV care continuum targets in a national U.S. sample of persons living with HIV receiving healthcare","author":"Williams","year":"2018","journal-title":"AIDS and Behavior"},{"key":"10.1016\/j.jsat.2019.11.002_bb0395","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.drugalcdep.2019.01.038","article-title":"Predictors of timely opioid agonist treatment initiation among veterans with and without HIV","volume":"198","author":"Wyse","year":"2019","journal-title":"Drug and Alcohol Dependence"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547219302703?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547219302703?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:49:55Z","timestamp":1760039395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547219302703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":76,"alternative-id":["S0740547219302703"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2019.11.002","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of initiation of and retention on medications for alcohol use disorder among people living with and without HIV","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2019.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}